Millipore Sigma Vibrant Logo

178462 Apolipoprotein C-II, Human Plasma, Very Low-Density Lipoprotein

178462
価格&在庫状況を照会

概要

Replacement Information

価格&在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
178462-50UGCN
在庫状況検索中…
現在国内在庫なし現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      樹脂アンプル 50 μg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示 
      値引
      ()
       
      弊社照会
      Description
      OverviewNative apolipoprotein C-II from human plasma. Found primarily in VLDL and chylomicrons. Functions as a cofactor for lipoprotein lipase. Elevated serum levels of Apo C-II are common in type I, III, IV, and V hyperlipoproteinemia. Low serum concentrations of Apo C-II are indicative of nephrotic syndrome (Tangier’s Disease).
      Catalogue Number178462
      Brand Family Calbiochem®
      SynonymsApo C-II
      References
      ReferencesBrunzell, J.D. 1989. in The Metabolic Basis of Inherited Disease, 6th Edition (Scriver, G.R., ed.) p. 1165, McGraw Hill, New York.
      Le, N.A., et al. 1988. J. Lipid Res. 29, 669.
      Jackson, R.L., and Holdsworth, G. 1986. Methods Enzymol. 128, Chapter 14.
      Product Information
      FormLyophilized
      FormulationLyophilized from 10 mM NH₄HCO₃, pH 7.4.
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥95% by SDS-PAGE
      SourcePrepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      Apolipoprotein C-II, Human Plasma, Very Low-Density Lipoprotein (M)SDS

      タイトル

      英語版製品安全データシート((M)SDS) 

      Apolipoprotein C-II, Human Plasma, Very Low-Density Lipoprotein 試験成績書(CoA)

      タイトルロット番号
      178462

      参考資料

      参考資料の概要
      Brunzell, J.D. 1989. in The Metabolic Basis of Inherited Disease, 6th Edition (Scriver, G.R., ed.) p. 1165, McGraw Hill, New York.
      Le, N.A., et al. 1988. J. Lipid Res. 29, 669.
      Jackson, R.L., and Holdsworth, G. 1986. Methods Enzymol. 128, Chapter 14.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision15-April-2008 RFH
      SynonymsApo C-II
      DescriptionNative apolipoprotein C-II from human plasma. Found primarily in VLDL and chylomicrons. Functions as a cofactor of lipoprotein lipase. Elevated serum levels of Apo C-II are often present in type I, III, IV and V hyperlipoproteinemia. Low serum concentrations of Apo C-II are indicative of nephrotic syndrome (Tangier disease).
      FormLyophilized
      FormulationLyophilized from 10 mM NH₄HCO₃, pH 7.4.
      SourcePrepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.
      Purity≥95% by SDS-PAGE
      SolubilityH₂O. Please refer to vial label for lot-specific volume prior to lyophilization.
      Storage -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesBrunzell, J.D. 1989. in The Metabolic Basis of Inherited Disease, 6th Edition (Scriver, G.R., ed.) p. 1165, McGraw Hill, New York.
      Le, N.A., et al. 1988. J. Lipid Res. 29, 669.
      Jackson, R.L., and Holdsworth, G. 1986. Methods Enzymol. 128, Chapter 14.